11/19
11:41 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "outperform" rating re-affirmed by analysts at William Blair.
11/19
11:41 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "outperform" rating re-affirmed by analysts at William Blair.
11/18
01:35 pm
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
10/31
08:35 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
10/16
07:39 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $26.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $26.00 price target on the stock.
10/16
05:07 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
10/16
05:07 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
10/3
09:47 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
10/3
09:47 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
10/3
08:17 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $22.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $22.00 price target on the stock.
10/3
08:17 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $22.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $22.00 price target on the stock.
10/3
06:41 am
lrmr
Larimar Therapeutics initiated with bullish view at Wedbush
Medium
Report
Larimar Therapeutics initiated with bullish view at Wedbush
10/3
06:41 am
lrmr
Larimar Therapeutics initiated with bullish view at Wedbush
Medium
Report
Larimar Therapeutics initiated with bullish view at Wedbush
10/2
08:08 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $15.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $15.00 price target on the stock.
9/4
08:06 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $16.00 price target on the stock.
High
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $16.00 price target on the stock.
9/4
05:41 am
lrmr
Rating for LRMR
High
Report
Rating for LRMR
9/4
05:41 am
lrmr
Rating for LRMR
High
Report
Rating for LRMR